Growth hormone response to clonidine and the cortisol response to dexamethasone in depressive patients

Psychiatry Research

Volumn 60, Issue 1, 1996, Pages 23-32

  Valdivieso, Sergio ^a   Duval, Fabrice ^b   Mokrani, Marie Claude ^b   Schaltenbrand, Nicolas ^b   Castro, Juarez Oliveira ^c   Crocq, Marc Antoine ^b   Macher, Jean Paul ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Centre Hospitalier de Rouffach   (France)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Dexamethasone suppression test; Hypothalamic pituitary adrenal axis; Major depression; Noradrenergic system

Indexed keywords

CLONIDINE; DEXAMETHASONE; GROWTH HORMONE; HYDROCORTISONE;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MELANCHOLIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029931934     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(95)02606-1     Document Type: Article

References (67)

1. Al-Damluji, S., Perry, L., Tomlin, S., Bouloux, P., Grossman, A., Rees, L.H. and Besser, G.M. (1987) Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. Neuroendocrinology 45, 68-76.
2. American Psychiatric Association. (1987) DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. edn. American Psychiatric Press, Washington, DC.
3. Amsterdam, J.D., Winokur, A., Lucki, I., Caroff, S., Snyder, P. and Rickels, K. (1983) A neuroendocrine test battery in bipolar patients and healthy subjects. Arch Gen Psychiatry 40, 515-521.
4. Arana, G.W., Workman, R.J. and Baldessarini, R.J. (1984) Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. Am J Psychiatry 141, 1619-1620.
5. APA Task Force on Laboratory Tests in Psychiatry. (1987) The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 146, 1253-1262.
6. Axelrod, J. and Reisine, T.D. (1984) Stress hormones: their interaction and regulation. Science 224, 452-459.
7. Banki, C.M., Bissette, G., Arato, M., O'Connor, L. and Nemeroff, C.B. (1987) CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 144, 873-877.
8. Barnes, R.F., Veith, R.C., Borson, S., Verhey, J., Raskind, M.A. and Halter, J.B. (1983). High levels of plasma catecholamines in dexamethasone-resistant depressed patients. Am J Psychiatry 140, 1623-1625.
9. Bech, P., Kastrup, M. and Rafaelsen, O.J. (1989) Echelles d'Anxieté, de Manie, de Depression, de Schizophrenie. Correspondance avec le DSM-III. Masson, Paris, pp. 43-57.
10. Brown, W.A., Johnston, R. and Mayfield, D. (1979) The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment. Am J Psychiatry 136, 543-547.
11. Brown, W.A. and Shuey, I. (1980) Response to dexamethasone and subtypes of depression. Arch Gen Psychiatry 37, 747-751.
12. Bryer, J.B., Borrelli, D.J., Matthews, E.J. and Kornetsky, C. (1983) The psychological correlates of the DST in depressed patients. Psychopharmacol Bull 4, 633-637.
13. Calogero, A.E., Galluci, W.T., Chrousos, G.P. and Gold, P.W. (1988) Catecholamine effects upon rat hypothalamic corticotropin releasing hormone secretion in vitro. J Clin Invest 82, 839-846.
14. Carroll, B.J. (1982) The dexamethasone suppression test for melancholia. Br J Psychiatry 140, 292-304.
15. Carroll, B.J. (1988) Diagnostic validity and laboratory studies: rules of the game. In: Robins, L.N. and Barrett, J.E. (Eds.), The Validity of Psychiatric Diagnosis. Raven Press, New York, pp. 229-245.
16. Carroll, B.J., Curtis, G.C. and Mendels, J. (1976) Neuroendocrine regulation in depression: I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 33, 1039-1044.
17. Carroll, B.J., Feinberg, M., Greden, J.F., Tarika, J., Albala, A.A., Haskett, R.F., James, N.W., Kronfol, Z., Lohr, N., Steiner, M., De Vigne, J.P. and Young, E. (1981) A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry 38, 15-22.
18. Carroll, B.J., Greden, J.F., Feinberg, M., James, N.M., Haskett, R.F., Steiner, M. and Tarika, J. (1980) Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression. Psychiatry Res 2, 251-258.
19. Charney, D.S., Heninger, G.R., Sternberg, D.E., Hafstad, K.M., Giddings, S. and Landis, D.H. (1982) Adrenergic receptor sensitivity in depression: effects of clonidine in depressed patients and healthy controls. Arch Gen Psychiatry 39, 290-294.
20. Cleary, P. and Guy, W. (1975) Factor analysis of the Hamilton Depression Scale. Presented at the International Symposium on the Evaluation on New Drugs in Clinical Psychopharmachology, Pisa, Italy.
21. Coryell, W. and Schlesser, M.A. (1981) Suicide and the dexamethasone suppression test in unipolar depression. Am J Psychiatry 138, 1120-1121.
22. Duval, F., Mokrani, M.C., Crocq, M.A., Weber, N., Rosenberg, S., Olivera, J., Valdivieso, S. and Macher, J.P. (1992) Multihormonal responses to clonidine, protireline and dexamethasone tests in psychiatry. In: Macher, J.P. and Crocq, M.A. (Eds.), New Prospects in Psychiatry: The Bioclinical Interface I. Elsevier, Amsterdam, pp. 192-203.
23. Endicott, J. and Spitzer, R.L. (1978) A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 35, 837-844.
24. Feinberg, M. and Carroll, B.J. (1984) Biologic "markers" for endogenous depression: effect of age, severity of illness, weight loss and polarity. Arch Gen Psychiatry 41, 1080-1085.
25. Ganong, W. (1980) Neurotransmitters and pituitary function: regulation of ACTH secretion. Fed Proc 39, 2923-2929.
26. Gold, P.W., Goodwin, F.K. and Chrousos, G.P. (1988) Clinical and biochemical manifestations of depression: relation to the neurobiology of stress. N Engl J Med 319 (2, part 2), 413-420.
27. Green, H.S. and Kane, J.M. (1983) The dexamethasone suppression test in depression. Clin Neuropharmacol 6, 7-24.
28. Hamilton, M. (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23, 56-62.
29. Harfstrand, A., Fuxe, K., Agnati, L.F., Eneroth, P., Zini, I., Zoli, M., Andersson, K., von Euler, G., Terenius, L., Muti, V. and Goldstein, M. (1986) Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat: relationship to neuroendocrine function. Neurochemistry 8, 355-376.
30. Hoehe, M., Valido, G. and Matussek, N. (1986) Growth hormone response to clonidine in endogenous depressive patients: evidence for a trait marker in depression. In: Shagass, C., Josiassen, R.C., Bridger, W.H., Weiss, K.J., Stoff, D., Simpson, G.M. (Eds.), Development in Psychiatry. Vol. 7: Biological Psychiatry. Elsevier, New York, pp. 788-790.
31. Jimerson, D.C., Insel, T.R., Reus, V.I. and Kopin, I.J. (1983) Increased plasma MHPG in dexamethasone-resistant depressed patients. Arch Gen Psychiatry 40, 173-176.
32. Kasper, S. and Beckmann, H. (1983) Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables. Acta Psychiatr Scand 68, 31-37.
33. Kathol, R.G., Jaeckle, R.S., Lopez, J.F. and Meller, W.H. (1989) Pathophysiology of HPA axis abnormalities in patients with major depression: an update. Am J Psychiatry 146, 311-317.
34. Koslow, S.H., Maas, J.W., Bowden, C.L., Davis, J.M., Hanin, I. and Javaid, J. (1983) CSF and urinary biogenic amines and metabolites in depression and mania: a controlled, univariate analysis. Arch Gen Psychiatry 40, 999-1010.
35. Lake, C.R., Pickar, D., Ziegler, M.G., Lipper, S., Slater, S. and Murphy, D.L. (1982) High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry 139, 1315-1318.
36. Maes, M., De Ruyter, M. and Suy, E. (1987) Prediction of sub-type and severity of depression by means of dexamethasone suppression test, L-tryptophan:competing amino acid ratio, and MHPG flow. Biol Psychiatry 22, 177-188.
37. Maes, M., Maes, L. and Suy, E. (1990) Symptom profiles of biological markers in depression: a multivariate study. Psychoneuroendocrinology 15, 29-37.
38. Maes, M., Minner, B., Suy, E., Vandervorst, C. and Raus, J. (1991) Coexisting dysregulation of both sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia. J Neural Transm [General Section] 85, 195-210.
39. Markey, K., Towle, A. and Sze, P. (1982) Glucocorticoid influence on tyrosine hydroxylase activity in mouse locus coeruleus during postnatal development. Endocrinology 111, 1519-1523.
40. Matussek, N. (1988) Catecholamines and mood: neuroendocrine aspects. Curr Top Neuroendocrinol 8, 141-182.
41. Matussek, N., Ackenheil, M., Hippius, H., Müller, F., Schöeder, H.-Th., Schultes, H. and Wasilewski, B. (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res 2, 25-36.
42. McWilliam, J.R., Meldrum, B.S. and Checkley, S.A. (1983). Changes in the sensitivity of the central alpha- and beta-adrenergic systems during desmethylimipramine treatment as assessed by plasma growth hormone response in the baboon. Psychopharmacology 80, 263-266.
43. Metz, C.E. (1978) Basic principles of ROC analysis. Semin Nucl Med 8, 283-298.
44. Nasr, S.J., Pandey, G., Altman, E.G., Gibbons, R., Gaviria, F.M. and Davis, J.M. (1983) Symptom profiles of patients with positive DST: a pilot study. Biol Psychiatry 18, 571-574.
45. Oishi, T. (1979) Possible role of brain norepinephrine in the hypothalamic hypophyseal adrenal system. Endocrinol Jpn 26, 399-409.
46. Olpe, H.R. and Jones, R.S. (1982) Excitatory effects of ACTH on noradrenergic neurons of the locus coeruleus in the rat. Brain Res 251, 177-179.
47. Post, R.M., Lake, C.R., Jimerson, D.C., Bunney, W.E., Jr., Wood, J.H., Ziegler, M.G. and Goodwin, F.K. (1978) Cerebrospinal fluid norepinephrine in affective illness. Am J Psychiatry 135, 907-912.
48. Reus, V.I. (1982) Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. Biol Psychiatry 17, 317-326.
49. Rivier, C. and Vale, W. (1985) Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function. Fed Proc 44, 189-194.
50. Rose, J.C., Goldsmith, P.C., Holland, F.J., Kaplan, S.L. and Ganong, W. F. (1976) Effect of electrical stimulation of the canine brain stem on the secretion of ACTH and growth hormone. Neuroendocrinology 22, 352-362.
51. Rosenbaum, A.M., Maruta, T., Schatzberg, A.F., Orsulak P.J., Jiang, N.S., Cole, J.O. and Schildkraut, J.J. (1983) Toward a biochemical classification of depressive disorders: VII Urinary free cortisol and urinary MHPG in depressions. Am J Psychiatry 140, 314-318.
52. Roy, A., DeJong, J. and Linnoila, M. (1989) Extraversion in pathological gamblers: correlates with indexes of noradrenergic function. Arch Gen Psychiatry 46, 679-681.
53. Roy, A., Jimerson, D.C. and Pickar, D. (1986) Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in depressive disorders: relationship to the dexamethasone suppression test. Am J Psychiatry 143, 846-851.
54. Rubin, A.L., Price, L.H., Charney, D. and Heninger, G.R. (1985) Noradrenergic function and the cortisol response to dexamethasone in depression. Psychiatry Res 15, 5-15.
55. Sachar, E.J. (1975) Evidence for neuroendocrine abnormalities in the major mental illnesses. In: Freedman, D.X. (Ed.), Biology of the Major Psychoses. Raven Press, New York.
56. Siever, L.J., Coccaro, E.F., Benjamin, E., Rubinstein, K. and Davis, K. L. (1986) Adrenergic and serotonergic receptor responsiveness in depression. In: Porter, R., Bock, G. and Clark, S. (Eds.), Antidepressant and Receptor Function. Ciba Foundation Symposium 123. Wiley, Chichester, UK, pp. 148-158.
57. Siever, L.J., Coccaro, E. and Davis, K. (1987) Noradrenergic dysregulation in depression. Actualités Psychiatriques 4, 58-65.
58. 2-adrenergic agonist clonidine. Biol Psychiatry 19, 131-156.
59. Siever, L.J., Uhde, T.W., Jimerson, D.C., Lake, C.R., Silberman, E.R., Post, R.M. and Murphy, D.L. (1984) Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects. Am J Psychiatry 141, 733-741.
60. Stokes, P.E., Stoll, P.M. and Koslow, S.H. (1984) Pretreatment DST and hypothalamic-pitutary-adrenocortical function in depressed patients and comparison groups: a multicenter study. Arch Gen Psychiatry 41, 257-267.
61. Sweeney, D., Maas, J. and Heninger, G. (1976) State anxiety, physical activity and urinary 3-methoxy-4-hydroxyphenethyleneglycol excretion. Arch Gen Psychiatry 35, 1418-1423.
62. Valentino, R.J., Foote, S.L. and Aston-Jones, G. (1983) Corticotropin-releasing hormone activates noradrenergic neurons of the locus coeruleus. Brain Res 270, 363-367.
63. Vestergaard, P., Sorensen, T., Hoppe, E., Rafaelsen, O.J., Yates, C. M. and Nicolaou, N. (1978) Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Acta Psychiatr Scand 58, 88-96.
64. 3H) WB 4101 to multiple sites in human brain. Biochem Pharmacol 30, 3115-3120.
65. Winokur, G., Behar, D., Van Valkenburg, C. and Lowry, M. (1978) Is a familial definition of depression both feasible and valid? J Nerv Ment Dis 166, 764-768.
66. Wyatt, R.J., Portnoy, B., Kupfer, D.J., Snyder, F. and Engelman, K. (1971) Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 24, 65-70.
67. Zimmerman, M., Pfohl, B.M. and Coryell, W.H. (1984) Appetite and weight change and the dexamethasone suppression test. Biol Psychiatry 19, 923-928.